Drug-resistant tuberculosis patient care journeys in South Africa: A pilot study using routine laboratory data

Loading...
Thumbnail Image

Date

2020

Journal Title

Journal ISSN

Volume Title

Publisher

International Union Against Tuberculosis and Lung Disease (The Union)

Abstract

hirteen districts in Eastern Cape (EC), KwaZulu-Natal (KZN) and Western Cape (WC) Provinces, South Africa. OBJECTIVE: To pilot a methodology for describing and visualising healthcare journeys among drug-resistant tuberculosis (DR-TB) patients using routine laboratory records. DESIGN: Laboratory records were obtained for 195 patients with laboratory-detected rifampicin-resistant TB (RR-TB) during July-September 2016. Health facility visits identified from these data were plotted to visualise patient healthcare journeys. Data were verified by facility visits. RESULTS: In the 9 months after the index RR-TB sample was collected, patients visited a mean of 2.3 health facilities (95% CI 2.1-2.6), with 9% visiting ≥4 facilities. The median distance travelled by patients from rural areas (116 km, interquartile range [IQR] 50-290) was greater than for urban patients (51 km, IQR 9-140). A median of 21% of patient's time was spent under the care of primary healthcare facilities: this was respectively 6%, 37% and 39% in KZN, EC and WC. Journey patterns were generally similar within districts. Some reflected a semi-centralised model of care where patients were referred to regional hospitals; other journeys showed greater involvement of primary care.

Description

Keywords

GIS, Health systems, Patient-focused, Tuberculosis, Mapping

Citation

Nicol, M. P. et al. (2020). Drug-resistant tuberculosis patient care journeys in South Africa: A pilot study using routine laboratory data. International Journal of Tuberculosis and Lung Disease, 24(1), 83-91